T0	Interventions 0 10	Argatroban
T1	Interventions 161 171	argatroban
T2	Interventions 207 247	percutaneous coronary intervention (PCI)
T3	Interventions 317 327	Argatroban
T4	Interventions 444 454	argatroban
T5	Interventions 584 594	argatroban
T6	Interventions 688 698	argatroban
T7	Interventions 711 726	(ARG250, ARG300
T8	Interventions 732 738	ARG350
T9	Interventions 824 856	one unfractionated heparin (UFH)
T10	Interventions 903 912	analyzed.
T11	Interventions 913 923	Argatroban
T12	Interventions 1056 1089	injection (ARG250: 86.1%, ARG300:
T13	Interventions 1097 1108	and ARG350:
T14	Interventions 1261 1274	in argatroban
T15	Interventions 1280 1286	in UFH
T16	Interventions 1343 1366	shortened in argatroban
T17	Interventions 1516 1559	groups (ARG250: 2.8%, ARG300: 0.0%, ARG350:
T18	Interventions 1565 1568	vs.
T19	Interventions 1609 1616	only in
T20	Interventions 1650 1668	occurred in ARG350
T21	Interventions 1676 1679	and
T22	Interventions 1698 1719	CONCLUSION Argatroban
T23	Interventions 1775 1786	compared to
T24	Interventions 1861 1880	undergoing elective